Literature DB >> 30370838

Abnormal Expression of miR-21 in Kidney Tissue of Dogs With X-Linked Hereditary Nephropathy: A Canine Model of Chronic Kidney Disease.

Sabrina D Clark1, Wenping Song2, Rachel Cianciolo3, George Lees1, Mary Nabity1, Shiguang Liu2.   

Abstract

MicroRNAs (miRNAs) are a group of small noncoding RNAs that act as regulators of posttranslational gene/protein expression and are known to play a key role in physiological and pathological processes. The objective of our study was to compare expression of miR-21 in renal tissue from dogs affected with chronic kidney disease (CKD) caused by X-linked hereditary nephropathy (XLHN), a disease equivalent to human Alport syndrome, to that from unaffected dogs. Additionally, we sought to characterize changes in relative mRNA expression of various genes associated with miR-21 function. miRNA was isolated from kidney tissue collected from both affected dogs and unaffected, age-matched littermates at defined milestones of disease progression, including end-stage renal disease (ESRD). Additionally, autopsy samples from affected dogs at ESRD and corresponding unaffected dogs were evaluated. Samples were scored based on histological changes, and relative expression of miR-21 and kidney disease-related genes was determined using quantitative real-time polymerase chain reaction. In affected dogs, significant upregulation of kidney miR-21 was first detected at the milestone corresponding with increased serum creatinine. Furthermore, miR-21 expression correlated significantly with urine protein: urine creatinine ratio, serum creatinine concentration, glomerular filtration rate, and histologic lesions (glomerular damage, tubular damage, chronic inflammation, and fibrosis). At end-stage disease, COL1A1, TGFB1 and its receptor, TGFB2, and Serpine1 were upregulated, while PPARA, PPARGC1A, ACADM, SOD1, and EGF were downregulated. In conclusion, miR-21 is abnormally upregulated in the kidneys of dogs with CKD caused by XLHN, which may play an important pathologic role in the progression of disease by dysregulating multiple pathways.

Entities:  

Keywords:  Alport syndrome; canine; chronic kidney disease; gene expression; histopathology; longitudinal study; miRNAs; renal function

Mesh:

Substances:

Year:  2018        PMID: 30370838     DOI: 10.1177/0300985818806050

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  3 in total

Review 1.  Recent findings on the role of microRNAs in genetic kidney diseases.

Authors:  Hassan Askari; Ehsan Raeis-Abdollahi; Mohammad Foad Abazari; Hassan Akrami; Sina Vakili; Amir Savardashtaki; Amir Tajbakhsh; Nima Sanadgol; Asaad Azarnezhad; Leila Rahmati; Payman Raise Abdullahi; Shohreh Zare Karizi; Ali Reza Safarpour
Journal:  Mol Biol Rep       Date:  2022-06-18       Impact factor: 2.742

Review 2.  MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.

Authors:  Linsey J F Peters; Jürgen Floege; Erik A L Biessen; Joachim Jankowski; Emiel P C van der Vorst
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 3.  Potential Renal Damage Biomarkers in Alport Syndrome-A Review of the Literature.

Authors:  Ana Marta Gomes; Daniela Lopes; Clara Almeida; Sofia Santos; Jorge Malheiro; Irina Lousa; Alberto Caldas Afonso; Idalina Beirão
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.